Delegat Group (DGL) H1 2026 earnings summary

Executive summary

• Achieved 3% growth in global case sales to 1.69 million and solid sales performance across most markets for H1 FY26, despite challenging wine industry conditions and U.S. tariffs.

• Operating NPAT increased by 5% to $29.7 million, with reported NPAT up 82% to $22.8 million year-over-year, mainly due to lower fair value and derivative losses.

• Operating EBITDA rose 6% to $65.6 million, and operating EBIT increased 5% to $50.7 million.

• Maintained premium brand positioning, expanded global distribution, and continued focus on value creation through price discipline and operational efficiencies.

• Strong operating cash flow and disciplined capital management enabled further debt reduction and financial stability.

Financial highlights

• Global case sales reached 1,688,000, up 54,000 cases (+3%) from H1 FY25.

• Operating EBITDA reached $65.6 million (37% of revenue), up 6% year-over-year; operating NPAT at $29.7 million, up 5%.

• Reported NPAT for the half year was $22.8 million, up 82% due to lower fair value losses.

• Sales revenue grew 1% to $179.6 million; operating gross margin improved to 49%.

• Cash from operations was $62.3 million, supporting a reduction in net debt to $307.0 million.

Outlook and guidance

• Full-year operating NPAT/profit guidance maintained at $50–$55 million.

• Volume guidance for FY26 remains at 3.3 million cases, implying 4% growth in H2.

• CapEx for FY26 expected at $26 million, with future years likely averaging $10–$15 million for replacement needs.